BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10597193)

  • 1. Nucleophosmin/B23 regulates the susceptibility of human leukemia HL-60 cells to sodium butyrate-induced apoptosis and inhibition of telomerase activity.
    Liu WH; Hsu CY; Yung BY
    Int J Cancer; 1999 Dec; 83(6):765-71. PubMed ID: 10597193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23.
    Liu WH; Yung BY
    Oncogene; 1998 Dec; 17(23):3055-64. PubMed ID: 9881708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity.
    Wu HL; Hsu CY; Liu WH; Yung BY
    Int J Cancer; 1999 Jun; 81(6):923-9. PubMed ID: 10362140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis.
    Hsu CY; Yung BY
    Int J Cancer; 2000 Nov; 88(3):392-400. PubMed ID: 11054668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells.
    You BJ; Huang IJ; Liu WH; Hung YB; Chang JH; Yung BY
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):683-90. PubMed ID: 10619186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells.
    Hsu CY; Yung BY
    Oncogene; 1998 Feb; 16(7):915-23. PubMed ID: 9484783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression.
    Wu MH; Chang JH; Yung BY
    Carcinogenesis; 2002 Jan; 23(1):93-100. PubMed ID: 11756229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc-mediated expression of nucleophosmin/B23 decreases during retinoic acid-induced differentiation of human leukemia HL-60 cells.
    Yung BY
    FEBS Lett; 2004 Dec; 578(3):211-6. PubMed ID: 15589822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of nucleophosmin/B23 in the response of HeLa cells to UV irradiation.
    Wu MH; Chang JH; Chou CC; Yung BY
    Int J Cancer; 2002 Jan; 97(3):297-305. PubMed ID: 11774280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased stability of nucleophosmin/B23 in anti-apoptotic effect of ras during serum deprivation.
    Chou CC; Yung BY
    Mol Pharmacol; 2001 Jan; 59(1):38-45. PubMed ID: 11125022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of sodium butyrate-induced apoptosis by vanadate in human promyelocytic leukemia cell line HL-60.
    Chang ST; Yung BY
    Biochem Biophys Res Commun; 1996 Apr; 221(3):594-601. PubMed ID: 8630006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
    Yeh CW; Huang SS; Lee RP; Yung BY
    Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis.
    Jiang PS; Yung BY
    Biochem Biophys Res Commun; 1999 Apr; 257(3):865-70. PubMed ID: 10208875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleophosmin/B23 regulates PCNA promoter through YY1.
    Weng JJ; Yung BY
    Biochem Biophys Res Commun; 2005 Sep; 335(3):826-31. PubMed ID: 16099430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa.
    Nozawa Y; Van Belzen N; Van der Made AC; Dinjens WN; Bosman FT
    J Pathol; 1996 Jan; 178(1):48-52. PubMed ID: 8778315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of nucleophosmin/B23 in TPA-induced megakaryocytic differentiation of K562 cells.
    Hsu CY; Yung BY
    Br J Cancer; 2003 Oct; 89(7):1320-6. PubMed ID: 14520467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism).
    Chan PK
    Exp Cell Res; 1992 Nov; 203(1):174-81. PubMed ID: 1426041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the ability of nucleophosmin/B23 to bind ATP.
    Chang JH; Lin JY; Wu MH; Yung BY
    Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):539-44. PubMed ID: 9445380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole enhancement of doxorubicin-induced translocation of nucleophosmin and inhibition of cell growth in HL-60 cells.
    Yung BY; Chang FJ; Luo KJ
    Int J Cancer; 1991 Oct; 49(4):592-7. PubMed ID: 1917161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity.
    Choi YH
    Int J Oncol; 2006 Nov; 29(5):1207-13. PubMed ID: 17016653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.